Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFlatulence is one of the more common digestive side effects of Mounjaro, and it tends to be most noticeable in the first few weeks of treatment. Tirzepatide slows how quickly food leaves the stomach, which alters gut motility and can lead to increased gas, bloating, and wind. For most people it settles; understanding why it happens makes it easier to manage. As a prescription-only medicine, Mounjaro must be assessed by a prescriber before you start — suitability depends on your full medical picture, not just your BMI.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works by activating two gut-hormone receptors (GIP and GLP-1) that are normally triggered by eating. One of the effects is a significant slowing of gastric emptying: food stays in the stomach longer before moving into the small intestine. That delay changes the rhythm the rest of the digestive tract is used to. Gas that would ordinarily pass through more quickly instead accumulates, producing bloating, belching, and flatulence. This is the same underlying mechanism that causes the nausea many people notice early on.
It is worth knowing that this is a predictable pharmacological effect, not a sign that something has gone wrong. The NHS patient information on tirzepatide lists flatulence and bloating among the common side effects, meaning they occur in more than one in a hundred users. The effect is most pronounced after starting treatment and after each dose increase, precisely because those are the moments when gastric emptying slows the most sharply. Your digestive system is adapting to a new signal. Most people find it settles within days to a couple of weeks once the body has adjusted.
If you are curious about the molecular detail behind why tirzepatide affects the gut so specifically, you can read about the tirzepatide peptide sequence to understand how its precise molecular structure produces these effects, and then explore the science behind Mounjaro to see how its dual-receptor action follows from that.
Yes, and this is the part people often underestimate. Because food moves slowly through the stomach on tirzepatide, choices that would cause modest bloating at full appetite can feel amplified when portions are smaller and digestion is already sluggish. High-fat foods are the most common culprit: fat delays gastric emptying independently of Mounjaro, so the two effects stack. Very fibrous foods (large portions of raw vegetables, legumes, wholegrain products) ferment in the gut and produce gas in the same way they always do, but the slower transit means more of it builds up before it can pass.
Carbonated drinks add gas directly. Eating quickly means swallowing air. And because appetite is reduced on Mounjaro, some people eat less regularly, which can disrupt the normal rhythm that keeps the bowel moving. Eating slowly, prioritising protein and cooked vegetables over large raw salads, limiting fizzy drinks, and keeping meal sizes modest tends to help. There is no universal rulebook, and a prescriber or dietitian is the right person to tailor advice to your specific pattern. What most people find is that the dietary sensitivity settles alongside the gas itself as the weeks go on.
For a broader look at what the first weeks of treatment actually feel like, the Mounjaro experience page covers what people commonly report.
Gas on Mounjaro is very common and usually harmless, but there are specific symptoms that need prompt medical attention rather than a dietary adjustment. Severe or persistent abdominal pain (particularly pain that radiates to the back, with or without vomiting) should not be dismissed as ordinary bloating. The MHRA highlighted acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines in a Drug Safety Update issued in January 2026; that warning covers tirzepatide. Pancreatitis can present as intense stomach pain that does not resolve on its own.
Signs of gallbladder trouble (sharp pain in the upper right abdomen, fever, jaundice) are also listed in the prescribing information and should be assessed by a doctor. Persistent vomiting or diarrhoea alongside significant bloating raises the risk of dehydration, which is worth addressing early. And if flatulence is accompanied by a change in stool colour, blood, or unexplained weight loss beyond what treatment would account for, see a GP. The day-to-day gas that peaks after a dose increase and fades within a fortnight is a nuisance; pain that does not settle is a different conversation entirely.
You can report any suspected side effects directly via the MHRA Yellow Card scheme. If you have questions about managing a specific symptom, our aftercare team is available seven days a week.
For the majority of people, gas and bloating improve meaningfully once the body has adjusted to a stable dose. The pattern tends to repeat briefly with each dose increase (the gut adapts, the symptom settles) and then quietens again. By the time someone reaches their maintenance dose, many find digestive side effects are considerably milder than they were in the first few weeks. That is the clinical picture reflected in the SURMOUNT programme data and in the experience our prescribers hear from patients.
A small number of people do find persistent GI symptoms make it difficult to continue at the prescribed dose, and in those cases a prescriber can review whether the titration pace is right or whether an alternative approach suits better. Rushing through dose increases faster than the licensed schedule tends to worsen GI effects, which is one reason the incremental schedule exists. Some people also notice other unexpected symptoms during titration, and if you have come across reports of Mounjaro hot flashes, our dedicated page explains what is known about that side effect and who tends to experience it.
Private treatment through a regulated pharmacy means you can have that conversation with a real prescriber at any point. At nume, every repeat order goes through a fresh clinical review before dispatch — your symptom picture is part of that. If you are considering starting treatment and want to understand what to expect, the Mounjaro overview is a good place to read before your consultation. Details on what the private route costs are on the Mounjaro cost page. When you are ready, check your eligibility with our prescribers, the consultation is free.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.